Australia's EchoIQ gains most in nearly 3 months after FDA update
17/09/2026 03:52
BUZZ-Australia's EchoIQ gains most in nearly 3 months after FDA update ** Shares of EchoIQ EIQ.AX rise as much as 14.6% to A$0.590, marking their biggest intraday pct gain since June 25
** Stock hits its highest level in a week
** Medical technology co says it sees a clear path to U.S. FDA clearance for its EchoSolv HF heart failure detection software, following receipt of FDA's determination & ongoing review of documentation
** Adds, FDA concerns were limited to statistical analysis and did not relate to the underlying technology of the product
** EIQ says the clearance could potentially be achieved over the coming quarters
** YTD, stock up 115.4%, including the day's moves
(Reporting by Paridhi Minda in Bengaluru)
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt